Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research.

CS 2.0 started with McKesson announcing that the Horizon suite of software used at VUMC would no longer be supported in 2018. We are using this announcement as a motivator to evaluate all our systems and plan for what our patients, our staff and our faculty need in the future.

As a gastroenterologist, Christopher Lind, M.D., says he is often the “butt” of jokes, but few people truly appreciate the role the gut plays in their happiness.

The partnership with Fisk through the Fisk-Vanderbilt Masters-to-PhD Bridge Program and other avenues, “presents us with an opportunity to see the results of our efforts impact an under-served community."

A new, separate set of Frequently Asked Questions for faculty is online now.

New faculty FAQ sheet answers questions about the transition.